| Year |
Citation |
Score |
| 2023 |
Knight DK, Funk RR, Belenko S, Dennis M, Wiese AL, Bartkowski JP, Dembo R, Elkington KS, Flynn PM, Harris PW, Hogue A, Palinkas LA, Robertson AA, Scott CK. Results of a national survey of substance use treatment services for youth under community supervision. Health & Justice. 11: 29. PMID 37515602 DOI: 10.1186/s40352-023-00233-w |
0.325 |
|
| 2019 |
Joe GW, Lehman WEK, Rowan GA, Knight K, Flynn PM. The role of physical and psychological health problems in the drug use treatment process. Journal of Substance Abuse Treatment. 102: 23-32. PMID 31202285 DOI: 10.1016/J.Jsat.2019.03.011 |
0.389 |
|
| 2019 |
Yang Y, Gray J, Joe GW, Flynn PM, Knight K. Treatment Retention Satisfaction, and Therapeutic Progress for Justice-Involved Individuals Referred to Community-Based Medication-Assisted Treatment. Substance Use & Misuse. 1-14. PMID 31030611 DOI: 10.1080/10826084.2019.1586949 |
0.389 |
|
| 2019 |
Knight DK, Joe GW, Becan JE, Crawley RD, Theisen SE, Flynn PM. Effectiveness of an Intervention for Improving Intrinsic Motivation among Adolescent Males in a Secure Substance Use Treatment Setting Criminal Justice and Behavior. 46: 101-114. DOI: 10.1177/0093854818804857 |
0.481 |
|
| 2018 |
Knight DK, Blue TR, Flynn PM, Knight K. The TCU Drug Screen 5: Identifying Justice-involved Individuals with Substance Use Disorders. Journal of Offender Rehabilitation. 57: 525-537. PMID 31666789 DOI: 10.1080/10509674.2018.1549180 |
0.306 |
|
| 2018 |
Becan JE, Bartkowski JP, Knight DK, Wiley TRA, DiClemente R, Ducharme L, Welsh WN, Bowser D, McCollister K, Hiller M, Spaulding AC, Flynn PM, Swartzendruber A, Dickson MF, Fisher JH, et al. A model for rigorously applying the Exploration, Preparation, Implementation, Sustainment (EPIS) framework in the design and measurement of a large scale collaborative multi-site study. Health & Justice. 6: 9. PMID 29654518 DOI: 10.1186/S40352-018-0068-3 |
0.386 |
|
| 2017 |
Christopoulos KA, Cunningham WE, Beckwith CG, Kuo I, Golin CE, Knight K, Flynn PM, Spaulding AC, Coffin LS, Kruszka B, Kurth A, Young JD, Mannheimer S, Crane HM, Kahana SY. Lessons Learned From the Implementation of Seek, Test, Treat, Retain Interventions Using Mobile Phones and Text Messaging to Improve Engagement in HIV Care for Vulnerable Populations in the United States. Aids and Behavior. PMID 28578543 DOI: 10.1007/S10461-017-1804-8 |
0.328 |
|
| 2017 |
Chandler R, Gordon MS, Kruszka B, Strand LN, Altice FL, Beckwith CG, Biggs ML, Cunningham W, Chris Delaney JA, Flynn PM, Golin CE, Knight K, Kral AH, Kuo I, Lorvick J, et al. Cohort profile: seek, test, treat and retain United States criminal justice cohort. Substance Abuse Treatment, Prevention, and Policy. 12: 24. PMID 28511680 DOI: 10.1186/S13011-017-0107-4 |
0.409 |
|
| 2017 |
Joe GW, Becan JE, Knight DK, Flynn PM. A structural model of treatment program and individual counselor leadership in innovation transfer. Bmc Health Services Research. 17: 230. PMID 28335765 DOI: 10.1186/S12913-017-2170-Y |
0.416 |
|
| 2017 |
Flynn PM. Pharmacotherapies as standalone treatments for addictions: why lessening won't work. Addiction (Abingdon, England). PMID 28124510 DOI: 10.1111/Add.13707 |
0.345 |
|
| 2015 |
Flynn PM, Brown BS. Matching Treatment to Rhetoric - A Challenge to Policy and Programming. Journal of Substance Abuse Treatment. PMID 26774843 DOI: 10.1016/J.Jsat.2015.06.025 |
0.395 |
|
| 2015 |
Knight DK, Joe GW, Crawley RD, Becan JE, Dansereau DF, Flynn PM. The effectiveness of the Treatment Readiness and Induction Program (TRIP) for improving during-treatment outcomes. Journal of Substance Abuse Treatment. PMID 26742724 DOI: 10.1016/J.Jsat.2015.11.007 |
0.493 |
|
| 2015 |
Crawley RD, Becan JE, Knight DK, Joe GW, Flynn PM. Predictors of Physical Altercation among Adolescents in Residential Substance Abuse Treatment. Deviant Behavior. 36: 996-1018. PMID 26622072 DOI: 10.1080/01639625.2014.982780 |
0.421 |
|
| 2015 |
Landrum B, Knight DK, Becan JE, Flynn PM. To Stay or Not To Stay: Adolescent Client, Parent, and Counselor Perspectives on Leaving Substance Abuse Treatment Early. Journal of Child & Adolescent Substance Abuse. 24: 344-354. PMID 26457049 DOI: 10.1080/1067828X.2013.844088 |
0.735 |
|
| 2015 |
Brown BS, Flynn PM. In Support of a National Treatment Evaluation Study. Substance Use & Misuse. 1-4. PMID 25775031 DOI: 10.3109/10826084.2015.1007660 |
0.502 |
|
| 2015 |
Flynn PM, Brown BS. Misrepresenting the Accomplishments of Treatment. Substance Use & Misuse. 1-3. PMID 25774461 DOI: 10.3109/10826084.2015.1007673 |
0.455 |
|
| 2015 |
Becan JE, Knight DK, Crawley RD, Joe GW, Flynn PM. Effectiveness of the Treatment Readiness and Induction Program for increasing adolescent motivation for change. Journal of Substance Abuse Treatment. 50: 38-49. PMID 25456094 DOI: 10.1016/J.Jsat.2014.10.002 |
0.542 |
|
| 2015 |
Yang Y, Knight K, Joe GW, Rowan GA, Lehman WE, Flynn PM. Gender as a moderator in predicting re-arrest among treated drug-involved offenders. Journal of Substance Abuse Treatment. 49: 65-70. PMID 25216813 DOI: 10.1016/J.Jsat.2014.08.001 |
0.316 |
|
| 2015 |
Knight DK, Dansereau DF, Becan JE, Rowan GA, Flynn PM. Effectiveness of a theoretically-based judgment and decision making intervention for adolescents. Journal of Youth and Adolescence. 44: 1024-38. PMID 24760288 DOI: 10.1007/S10964-014-0127-6 |
0.443 |
|
| 2015 |
Yang Y, Gray J, Pankow J, Flynn PM, Knight K. Investigating treatment satisfaction and progress for offenders referred to community-based drug addiction treatment Addiction Science & Clinical Practice. 10. DOI: 10.1186/1940-0640-10-S1-A75 |
0.444 |
|
| 2014 |
Knight DK, Becan JE, Landrum B, Joe GW, Flynn PM. Screening and assessment tools for measuring adolescent client needs and functioning in substance abuse treatment. Substance Use & Misuse. 49: 902-18. PMID 24621083 DOI: 10.3109/10826084.2014.891617 |
0.721 |
|
| 2014 |
Joe GW, Knight DK, Becan JE, Flynn PM. Recovery among adolescents: models for post-treatment gains in drug abuse treatments. Journal of Substance Abuse Treatment. 46: 362-73. PMID 24238715 DOI: 10.1016/J.Jsat.2013.10.007 |
0.511 |
|
| 2014 |
Crawley R, Knight D, Becan JE, Flynn P. Problem behaviors and criminal thinking among adolescents in residential substance abuse treatment Drug and Alcohol Dependence. 140. DOI: 10.1016/J.Drugalcdep.2014.02.131 |
0.351 |
|
| 2014 |
Becan JE, Knight D, Joe G, Crawley R, Flynn P. Effectiveness of the treatment retention and induction program (TRIP) for increasing adolescent motivation for change Drug and Alcohol Dependence. 140. DOI: 10.1016/J.Drugalcdep.2014.02.054 |
0.492 |
|
| 2013 |
Yang Y, Knight K, Joe GW, Rowan-Szal GA, Lehman WEK, Flynn PM. The Influence of Client Risks and Treatment Engagement on Recidivism. Journal of Offender Rehabilitation. 52: 544-564. PMID 29353986 DOI: 10.1080/10509674.2013.840353 |
0.471 |
|
| 2013 |
Knight DK, Becan JE, Flynn PM. The Impact of Staff Turnover on Workplace Demands and Coworker Relationships. Counselor (Deerfield Beach, Fla.). 14: 20-23. PMID 27540331 |
0.362 |
|
| 2013 |
Dansereau DF, Knight DK, Flynn PM. Improving Adolescent Judgment and Decision Making. Professional Psychology, Research and Practice. 44. PMID 24391350 DOI: 10.1037/A0032495 |
0.313 |
|
| 2012 |
Joe GW, Knight K, Simpson DD, Flynn PM, Morey JT, Bartholomew NG, Tindall MS, Burdon WM, Hall EA, Martin SS, O'Connell DJ. An Evaluation of Six Brief Interventions that Target Drug-Related Problems in Correctional Populations. Journal of Offender Rehabilitation. 51: 9-33. PMID 22547911 DOI: 10.1080/10509674.2012.633020 |
0.359 |
|
| 2012 |
Lehman WE, Greener JM, Flynn PM. Organizational Readiness for Change in Correctional and Community Substance Abuse Programs. Journal of Offender Rehabilitation. 51: 96-114. PMID 22505796 DOI: 10.1080/10509674.2012.633022 |
0.441 |
|
| 2012 |
Friedmann PD, Hoskinson R, Gordon M, Schwartz R, Kinlock T, Knight K, Flynn PM, Welsh WN, Stein LA, Sacks S, O'Connell DJ, Knudsen HK, Shafer MS, Hall E, Frisman LK, et al. Medication-assisted treatment in criminal justice agencies affiliated with the criminal justice-drug abuse treatment studies (CJ-DATS): availability, barriers, and intentions. Substance Abuse. 33: 9-18. PMID 22263709 DOI: 10.1080/08897077.2011.611460 |
0.424 |
|
| 2012 |
Flynn PM, Knight DK, Godley MD, Knudsen HK. Introduction to the special issue on organizational dynamics within substance abuse treatment: a complex human activity system. Journal of Substance Abuse Treatment. 42: 109-15. PMID 22154828 DOI: 10.1016/J.Jsat.2011.10.029 |
0.476 |
|
| 2012 |
Broome KM, Knight DK, Joe GW, Flynn PM. Treatment program operations and costs. Journal of Substance Abuse Treatment. 42: 125-33. PMID 22154033 DOI: 10.1016/J.Jsat.2011.10.013 |
0.395 |
|
| 2012 |
Lehman WE, Becan JE, Joe GW, Knight DK, Flynn PM. Resources and training in outpatient substance abuse treatment facilities. Journal of Substance Abuse Treatment. 42: 169-78. PMID 22154031 DOI: 10.1016/J.Jsat.2011.10.018 |
0.338 |
|
| 2012 |
Becan JE, Knight DK, Flynn PM. Innovation adoption as facilitated by a change-oriented workplace. Journal of Substance Abuse Treatment. 42: 179-90. PMID 22154030 DOI: 10.1016/J.Jsat.2011.10.014 |
0.395 |
|
| 2012 |
Landrum B, Knight DK, Flynn PM. The impact of organizational stress and burnout on client engagement. Journal of Substance Abuse Treatment. 42: 222-30. PMID 22154029 DOI: 10.1016/J.Jsat.2011.10.011 |
0.729 |
|
| 2012 |
Knight DK, Becan JE, Flynn PM. Organizational consequences of staff turnover in outpatient substance abuse treatment programs. Journal of Substance Abuse Treatment. 42: 143-50. PMID 22154028 DOI: 10.1016/J.Jsat.2011.10.009 |
0.493 |
|
| 2012 |
Knight DK, Landrum B, Becan JE, Flynn PM. Program needs and change orientation: implications for counselor turnover. Journal of Substance Abuse Treatment. 42: 159-68. PMID 22154025 DOI: 10.1016/J.Jsat.2011.10.019 |
0.72 |
|
| 2012 |
Knight K, Flynn PM. Clinical trials involving prisoners: a bioethical perspective Clinical Investigation. 2: 1147-1149. DOI: 10.4155/Cli.12.123 |
0.368 |
|
| 2012 |
Flynn PM. Improving judgment and decision-making among youth in treatment: Emerging evidence, implications for retention, and implementation issues Journal of Substance Abuse Treatment. 43. DOI: 10.1016/J.Jsat.2012.08.098 |
0.355 |
|
| 2011 |
Lehman WE, Simpson DD, Knight DK, Flynn PM. Integration of treatment innovation planning and implementation: strategic process models and organizational challenges. Psychology of Addictive Behaviors : Journal of the Society of Psychologists in Addictive Behaviors. 25: 252-61. PMID 21443294 DOI: 10.1037/A0022682 |
0.408 |
|
| 2011 |
Flynn PM, Brown BS. Implementation research: Issues and prospects. Addictive Behaviors. 36: 566-9. PMID 21236584 DOI: 10.1016/J.Addbeh.2010.12.020 |
0.406 |
|
| 2011 |
Edwards JR, Knight DK, Flynn PM. Organizational correlates of service availability in outpatient substance abuse treatment programs. The Journal of Behavioral Health Services & Research. 38: 432-43. PMID 21107915 DOI: 10.1007/S11414-010-9231-X |
0.365 |
|
| 2011 |
Simpson DD, Joe GW, Dansereau DF, Flynn PM. Addiction treatment outcomes, process and change: Texas Institute of Behavioral Research at Texas Christian University. Addiction (Abingdon, England). 106: 1733-40. PMID 20840168 DOI: 10.1111/J.1360-0443.2010.03121.X |
0.48 |
|
| 2011 |
Knight DK, Broome KM, Edwards JR, Flynn PM. Supervisory turnover in outpatient substance abuse treatment. The Journal of Behavioral Health Services & Research. 38: 80-90. PMID 19949883 DOI: 10.1007/S11414-009-9198-7 |
0.521 |
|
| 2011 |
Thompson SJ, Bender K, Cardoso JB, Flynn PM. Experiential Activities in Family Therapy: Perceptions of Caregivers and Youth Journal of Child and Family Studies. 20: 560-568. DOI: 10.1007/S10826-010-9428-X |
0.322 |
|
| 2010 |
Knight DK, Edwards JR, Flynn PM. Predictors of change in the provision of services within outpatient substance abuse treatment programs. Journal of Public Health Management and Practice : Jphmp. 16: 553-63. PMID 20885186 DOI: 10.1097/Phh.0B013E3181Cb4354 |
0.395 |
|
| 2010 |
Edwards JR, Knight DK, Broome KM, Flynn PM. The development and validation of a transformational leadership survey for substance use treatment programs. Substance Use & Misuse. 45: 1279-302. PMID 20509734 DOI: 10.3109/10826081003682834 |
0.332 |
|
| 2009 |
Conover CJ, Weaver M, Ang A, Arno P, Flynn PM, Ettner SL. Costs of care for people living with combined HIV/AIDS, chronic mental illness, and substance abuse disorders. Aids Care. 21: 1547-59. PMID 20024734 DOI: 10.1080/09540120902923006 |
0.311 |
|
| 2009 |
Thompson SJ, Bender K, Windsor LC, Flynn PM. Keeping families engaged: the effects of home-based family therapy enhanced with experiential activities. Social Work Research. 33: 121-126. PMID 20011133 DOI: 10.1093/Swr/33.2.121 |
0.358 |
|
| 2009 |
Broome KM, Knight DK, Edwards JR, Flynn PM. Leadership, burnout, and job satisfaction in outpatient drug-free treatment programs. Journal of Substance Abuse Treatment. 37: 160-70. PMID 19339143 DOI: 10.1016/J.Jsat.2008.12.002 |
0.523 |
|
| 2009 |
Sacks S, Cleland CM, Melnick G, Flynn PM, Knight K, Friedmann PD, Prendergast ML, Coen C. Violent offenses associated with co-occurring substance use and mental health problems: evidence from CJDATS. Behavioral Sciences & the Law. 27: 51-69. PMID 19156677 DOI: 10.1002/Bsl.850 |
0.402 |
|
| 2009 |
Best D, Day E, Campbell A, Flynn PM, Simpson DD. Relationship between drug treatment engagement and criminal thinking style among drug-using offenders. European Addiction Research. 15: 71-7. PMID 19142006 DOI: 10.1159/000189785 |
0.406 |
|
| 2009 |
Flynn PM, Broome KM, Beaston-Blaakman A, Knight DK, Horgan CM, Shepard DS. Treatment Cost Analysis Tool (TCAT) for estimating costs of outpatient treatment services. Drug and Alcohol Dependence. 100: 47-53. PMID 19004576 DOI: 10.1016/J.Drugalcdep.2008.08.015 |
0.399 |
|
| 2008 |
Knight DK, Broome KM, Simpson DD, Flynn PM. Program structure and counselor-client contact in outpatient substance abuse treatment. Health Services Research. 43: 616-34. PMID 18370970 DOI: 10.1111/J.1475-6773.2007.00778.X |
0.437 |
|
| 2008 |
Flynn PM, Brown BS. Co-occurring disorders in substance abuse treatment: issues and prospects. Journal of Substance Abuse Treatment. 34: 36-47. PMID 17574791 DOI: 10.1016/J.Jsat.2006.11.013 |
0.452 |
|
| 2007 |
Thompson SJ, Bender K, Lantry J, Flynn PM. Treatment Engagement: Building Therapeutic Alliance in Home-Based Treatment with Adolescents and their Families. Contemporary Family Therapy. 29: 39-55. PMID 20556209 DOI: 10.1007/S10591-007-9030-6 |
0.404 |
|
| 2007 |
Thompson SJ, Kim J, McManus H, Flynn P, Kim H. Peer Relationships: Comparison of homeless youth in the U.S. and South Korea. International Social Work. 50: 783-795. PMID 19920883 DOI: 10.1177/0020872807079922 |
0.352 |
|
| 2007 |
Bender K, Thompson SJ, McManus H, Lantry J, Flynn PM. Capacity for Survival: Exploring Strengths of Homeless Street Youth. Child & Youth Care Forum. 36: 25-42. PMID 19915687 DOI: 10.1007/S10566-006-9029-4 |
0.37 |
|
| 2007 |
Broome KM, Flynn PM, Knight DK, Simpson DD. Program structure, staff perceptions, and client engagement in treatment. Journal of Substance Abuse Treatment. 33: 149-58. PMID 17434709 DOI: 10.1016/J.Jsat.2006.12.030 |
0.52 |
|
| 2007 |
Simpson DD, Flynn PM. Moving innovations into treatment: A stage-based approach to program change. Journal of Substance Abuse Treatment. 33: 111-20. PMID 17434704 DOI: 10.1016/J.Jsat.2006.12.023 |
0.486 |
|
| 2007 |
Joe GW, Flynn PM, Broome KM, Simpson DD. Patterns of drug use and expectations in methadone patients. Addictive Behaviors. 32: 1640-56. PMID 17218066 DOI: 10.1016/J.Addbeh.2006.11.021 |
0.385 |
|
| 2007 |
Garner BR, Knight K, Flynn PM, Morey JT, Simpson DD. Measuring offender attributes and engagement in treatment using the client Evaluation of Self and treatment Criminal Justice and Behavior. 34: 1113-1130. DOI: 10.1177/0093854807304345 |
0.505 |
|
| 2007 |
Shields JJ, Broome KM, Delany PJ, Fletcher BW, Flynn PM. Religion and substance abuse treatment: Individual and program effects Journal For the Scientific Study of Religion. 46: 355-371. DOI: 10.1111/J.1468-5906.2007.00363.X |
0.521 |
|
| 2006 |
Rampazzo L, De Angeli M, Serpelloni G, Simpson DD, Flynn PM. Italian survey of organizational functioning and readiness for change: a cross-cultural transfer of treatment assessment strategies. European Addiction Research. 12: 176-81. PMID 16968992 DOI: 10.1159/000094419 |
0.495 |
|
| 2006 |
Thompson SJ, McManus H, Lantry J, Windsor L, Flynn P. Insights from the street: Perceptions of services and providers by homeless young adults Evaluation and Program Planning. 29: 34-43. DOI: 10.1016/J.Evalprogplan.2005.09.001 |
0.309 |
|
| 2004 |
Conover CJ, Ettner SL, Weaver M, Flynn PM, Porto JV. Economic evaluations of HIV treatment and health research with people diagnosed with HIV infection and co-occurring mental health and substance use disorders Aids Care - Psychological and Socio-Medical Aspects of Aids/Hiv. 16. PMID 15736825 DOI: 10.1080/09540120412331315268 |
0.311 |
|
| 2003 |
Flynn PM, Joe GW, Broome KM, Simpson DD, Brown BS. Recovery from opioid addiction in DATOS. Journal of Substance Abuse Treatment. 25: 177-86. PMID 14670523 DOI: 10.1016/S0740-5472(03)00125-9 |
0.393 |
|
| 2003 |
Fletcher BW, Broome KM, Delany PJ, Shields J, Flynn PM. Patient and program factors in obtaining supportive services in DATOS. Journal of Substance Abuse Treatment. 25: 165-75. PMID 14670522 DOI: 10.1016/S0740-5472(03)00126-0 |
0.421 |
|
| 2003 |
Flynn PM, Joe GW, Broome KM, Simpson DD, Brown BS. Looking back on cocaine dependence: reasons for recovery. The American Journal On Addictions / American Academy of Psychiatrists in Alcoholism and Addictions. 12: 398-411. PMID 14660154 DOI: 10.1111/J.1521-0391.2003.Tb00483.X |
0.425 |
|
| 2002 |
Brown BS, Flynn PM. The federal role in drug abuse technology transfer: a history and perspective. Journal of Substance Abuse Treatment. 22: 245-57. PMID 12072168 DOI: 10.1016/S0740-5472(02)00228-3 |
0.337 |
|
| 2001 |
Flynn PM, Simpson DD, Anglin MD, Hubbard RL. Comment on "nonresponse and selection bias in treatment follow-up studies". Substance Use & Misuse. 36: 1749-51, 1753-7. PMID 11758821 DOI: 10.1081/Ja-100107577 |
0.346 |
|
| 2001 |
Delany PJ, Broome KM, Flynn PM, Fletcher BW. Treatment Service Patterns and Organizational Structures An Analysis of Programs in DATOS-A Journal of Adolescent Research. 16: 590-607. DOI: 10.1177/0743558401166004 |
0.452 |
|
| 1999 |
Flynn PM, Kristiansen PL, Porto JV, Hubbard RL. Costs and benefits of treatment for cocaine addiction in DATOS Drug and Alcohol Dependence. 57: 167-174. PMID 10617100 DOI: 10.1016/S0376-8716(99)00083-6 |
0.387 |
|
| 1997 |
Rounds-Bryant JL, Flynn PM, Craighead LW. Relationship between self-efficacy perceptions and in-treatment drug use among regular cocaine users. The American Journal of Drug and Alcohol Abuse. 23: 383-95. PMID 9261487 DOI: 10.3109/00952999709016884 |
0.39 |
|
| 1997 |
Craddock SG, Rounds-Bryant JL, Flynn PM, Hubbard RL. Characteristics and pretreatment behaviors of clients entering drug abuse treatment: 1969 to 1993. The American Journal of Drug and Alcohol Abuse. 23: 43-59. PMID 9048146 DOI: 10.3109/00952999709001686 |
0.445 |
|
| 1997 |
Hubbard RL, Craddock SG, Flynn PM, Anderson J, Etheridge RM. Overview of 1-year follow-up outcomes in the Drug Abuse Treatment Outcome Study (DATOS) Psychology of Addictive Behaviors. 11: 261-278. DOI: 10.1037/0893-164X.11.4.261 |
0.404 |
|
| 1997 |
Etheridge RM, Hubbard RL, Anderson J, Craddock SG, Flynn PM. Treatment structure and program services in the Drug Abuse Treatment Outcome Study (DATOS) Psychology of Addictive Behaviors. 11: 244-260. DOI: 10.1037/0893-164X.11.4.244 |
0.508 |
|
| 1997 |
Flynn PM, Craddock SG, Hubbard RL, Anderson J, Etheridge RM. Methodological overview and research design for the Drug Abuse Treatment Outcome Study (DATOS) Psychology of Addictive Behaviors. 11: 230-243. DOI: 10.1037/0893-164X.11.4.230 |
0.5 |
|
| 1996 |
Flynn PM, Craddock SG, Luckey JW, Hubbard RL, Dunteman GH. Comorbidity of Antisocial Personality and Mood Disorders among Psychoactive Substance-Dependent Treatment Clients Journal of Personality Disorders. 10: 56-67. DOI: 10.1521/Pedi.1996.10.1.56 |
0.355 |
|
| 1994 |
Hoffman JA, Caudill BD, Koman JJ, Luckey JW, Flynn PM, Hubbard RL. Comparative cocaine abuse treatment strategies: enhancing client retention and treatment exposure. Journal of Addictive Diseases. 13: 115-28. PMID 7734463 DOI: 10.1300/J069V13N04_01 |
0.452 |
|
| 1993 |
Hoffman JA, Caudill BD, Koman JJ, Luckey JW, Flynn PM, Hubbard RL. Comparative cocaine abuse treatments: Client retention and treatment exposure Pharmacology, Biochemistry and Behavior. 46: 508. DOI: 10.1016/0091-3057(93)90445-Y |
0.369 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2006 |
Knight K, Garner BR, Simpson DD, Morey JT, Flynn PM. An assessment for criminal thinking Crime and Delinquency. 52: 159-177. DOI: 10.1177/0011128705281749 |
0.289 |
|
| 2018 |
Hill LM, Golin CE, Gottfredson NC, Pence BW, DiPrete B, Carda-Auten J, Groves JS, Napravnik S, Wohl D, Knight K, Flynn PM. Drug Use Mediates the Relationship Between Depressive Symptoms and Adherence to ART Among Recently Incarcerated People Living with HIV. Aids and Behavior. PMID 30535731 DOI: 10.1007/S10461-018-2355-3 |
0.285 |
|
| 2019 |
DiPrete BL, Pence BW, Golin CE, Knight K, Flynn PM, Carda-Auten J, Groves JS, Powers KA, White BL, Napravnik S, Wohl DA. Antiretroviral Adherence Following Prison Release in a Randomized Trial of the imPACT Intervention to Maintain Suppression of HIV Viremia. Aids and Behavior. PMID 30963321 DOI: 10.1007/S10461-019-02488-7 |
0.284 |
|
| 2012 |
Knight K, Simpson DD, Flynn PM. Introduction to the Special Double Issue: Brief Addiction Interventions and Assessment Tools for Criminal Justice Journal of Offender Rehabilitation. 51: 1-8. DOI: 10.1080/10509674.2012.633016 |
0.279 |
|
| 1992 |
McCann JT, Flynn PM, Gersh DM. MCMI-II diagnosis of borderline personality disorder: base rates versus prototypic items. Journal of Personality Assessment. 58: 105-14. PMID 1545335 DOI: 10.1207/S15327752Jpa5801_10 |
0.275 |
|
| 2019 |
Cunningham WE, Nance RM, Golin CE, Flynn P, Knight K, Beckwith CG, Kuo I, Spaulding A, Taxman FS, Altice F, Delaney JA, Crane HM, Springer SA. Self-reported antiretroviral therapy adherence and viral load in criminal justice-involved populations. Bmc Infectious Diseases. 19: 913. PMID 31664910 DOI: 10.1186/S12879-019-4443-Z |
0.273 |
|
| 2015 |
Sidibe T, Golin C, Turner K, Fray N, Fogel C, Flynn P, Gould M, Knight K, Wohl D. Provider perspectives regarding the health care needs of a key population: HIV-infected prisoners after incarceration. The Journal of the Association of Nurses in Aids Care : Janac. 26: 556-69. PMID 26279385 DOI: 10.1016/J.Jana.2015.05.001 |
0.272 |
|
| 1997 |
Flynn PM, McCann JT, Luckey JW, Rounds-Bryant JL, Theisen AC, Hoffman JA, Koman JJ. Drug dependence scale in the Millon Clinical Multiaxial inventory. Substance Use & Misuse. 32: 733-48. PMID 9178439 DOI: 10.3109/10826089709039373 |
0.267 |
|
| 2016 |
Golin CE, Knight K, Carda-Auten J, Gould M, Groves J, L White B, Bradley-Bull S, Amola K, Fray N, Rosen DL, Mugavaro MJ, Pence BW, Flynn PM, Wohl D. Individuals motivated to participate in adherence, care and treatment (imPACT): development of a multi-component intervention to help HIV-infected recently incarcerated individuals link and adhere to HIV care. Bmc Public Health. 16: 935. PMID 27596559 DOI: 10.1186/S12889-016-3511-1 |
0.266 |
|
| 1993 |
Flynn PM, Brown BS, Hoffman JA, Luckey JW, Craddock SG, Hubbard RL, Needle R, Schneider SJ, Koman JJ, Karson S, Vahid M, Palsgrove GL. Relationship between drug preference and clinical syndromes and diagnoses Pharmacology, Biochemistry and Behavior. 46: 507-508. DOI: 10.1016/0091-3057(93)90442-V |
0.25 |
|
| 2018 |
Hussong AM, Gottfredson NC, Bauer DJ, Curran PJ, Haroon M, Chandler R, Kahana SY, Delaney JAC, Altice FL, Beckwith CG, Feaster DJ, Flynn PM, Gordon MS, Knight K, Kuo I, et al. Approaches for creating comparable measures of alcohol use symptoms: Harmonization with eight studies of criminal justice populations. Drug and Alcohol Dependence. 194: 59-68. PMID 30412898 DOI: 10.1016/J.Drugalcdep.2018.10.003 |
0.249 |
|
| 1993 |
Caudill BD, Hoffman JA, Flynn PM, Luckey JW. Social support systems in crack abusers with chemically dependent parents Pharmacology, Biochemistry and Behavior. 46: 506. DOI: 10.1016/0091-3057(93)90434-U |
0.248 |
|
| 2014 |
Yang Y, Knight K, Joe GW, Rowan-Szal GA, Lehman WE, Flynn PM. Sex/gender differences and the impact of risk factors and psychosocial functioning on the time to re-arrest among offenders treated for substance use Drug and Alcohol Dependence. 140. DOI: 10.1016/J.Drugalcdep.2014.02.680 |
0.241 |
|
| 2017 |
Wohl DA, Golin CE, Knight K, Gould M, Carda-Auten J, Groves JS, Napravnik S, Cole SR, White BL, Fogel C, Rosen DL, Mugavaro MJ, Pence BW, Flynn PM. A Randomized Controlled Trial of an Intervention to Maintain Suppression of HIV Viremia Following Prison Release: The imPACT Trial. Journal of Acquired Immune Deficiency Syndromes (1999). PMID 28277487 DOI: 10.1097/Qai.0000000000001337 |
0.235 |
|
| 2019 |
Joe GW, Lehman WEK, Rowan GA, Knight K, Flynn PM. Evaluating the impact of a targeted brief HIV intervention on multiple inter-related HIV risk factors of knowledge and attitudes among incarcerated drug users Journal of Hiv\/Aids & Social Services. 18: 61-79. DOI: 10.1080/15381501.2019.1584140 |
0.234 |
|
| 2015 |
Flynn PM, Pankow J. Expanding Access and Utilization of Behavioral Therapies Through the Use
of TechnologyExpanding Access and Utilization of Behavioral Therapies
Through the Use of Technology Psyccritiques. 6060. DOI: 10.1037/A0039546 |
0.217 |
|
| 2009 |
Flynn PM. Illuminating the magic and mystery behind evidence-based practices. Psyccritiques. 54. DOI: 10.1037/A0014328 |
0.202 |
|
| 2000 |
Flynn PM. Community as Method: Therapeutic Communities for Special Populations and Special Settings Journal of Substance Abuse Treatment. 18: 92. DOI: 10.1016/S0740-5472(99)00060-4 |
0.199 |
|
| 2000 |
Brown BS, Flynn PM. A Review of “The Fix, by Michael Massing, New York, NY: Simon & Schuster, 1998. $25.00, 336 pages. ISBN 0-684-80960-5” Substance Use & Misuse. 35: 1613-1615. DOI: 10.3109/10826080009148233 |
0.18 |
|
| 2006 |
Ye Y, Stevens A, Berto D, Frick U, Hunt N, Kerschl V, McSweeney T, Oeuvray K, Puppo I, Maria AS, Schaaf S, Trinkl B, Uchtenhagen A, Werdenich W, Turyabahika-Thyen K, ... ... Flynn PM, et al. Contents Vol. 12, 2006 European Addiction Research. 12: 243-244. DOI: 10.1159/000095799 |
0.178 |
|
| 2006 |
Ye Y, Stevens A, Berto D, Frick U, Hunt N, Kerschl V, McSweeney T, Oeuvray K, Puppo I, Maria AS, Schaaf S, Trinkl B, Uchtenhagen A, Werdenich W, Turyabahika-Thyen K, ... ... Flynn PM, et al. Subject Index Vol. 12, 2006 European Addiction Research. 12: 242-242. DOI: 10.1159/000095798 |
0.173 |
|
| 2019 |
Joe GW, Lehman WEK, Rowan GA, Knight K, Flynn PM. Evaluating the Impact of a Targeted Brief HIV Intervention on Multiple Inter-Related HIV Risk Factors of Knowledge and Attitudes among Incarcerated Drug Users. Journal of Hiv/Aids & Social Services. 18: 61-79. PMID 36092275 DOI: 10.1080/15381501.2019.1584140 |
0.162 |
|
| 2012 |
Ipp L, Flynn P, Blanco J, Green D, Boachie-Adjei O, Kozich J, Chan G, Denneen J, Widmann R. The findings of preoperative cardiac screening studies in adolescent idiopathic scoliosis. Journal of Pediatric Orthopedics. 31: 764-6. PMID 21926874 DOI: 10.1097/BPO.0b013e31822f14d6 |
0.146 |
|
| 2012 |
Tan WW, Allred JB, Salim M, Flynn P, Fishkin PA, Stella PJ, Wiesenfeld M, Bernath AM, Fitch TR, Perez EA. Phase II interventional study (N0337) of capecitabine in combination with vinorelbine and trastuzumab for first- or second-line treatment of HER2-positive metastatic breast cancer: a north central cancer treatment group trial. Clinical Breast Cancer. 12: 81-6. PMID 22444716 DOI: 10.1016/j.clbc.2012.01.001 |
0.116 |
|
| 2022 |
Alkhushayni S, Al-Zaleq D, Andradi L, Flynn P. The Application of Differing Machine Learning Algorithms and Their Related Performance in Detecting Skin Cancers and Melanomas. Journal of Skin Cancer. 2022: 2839162. PMID 35573163 DOI: 10.1155/2022/2839162 |
0.086 |
|
| 2013 |
Powell A, Flynn P, Rischbieth S, McKellar D. Managing severe aggression in frontotemporal dementia. Australasian Psychiatry : Bulletin of Royal Australian and New Zealand College of Psychiatrists. 22: 86-9. PMID 24176944 DOI: 10.1177/1039856213510576 |
0.08 |
|
| 2011 |
Herbst RS, Ansari R, Bustin F, Flynn P, Hart L, Otterson GA, Vlahovic G, Soh CH, O'Connor P, Hainsworth J. Efficacy of bevacizumab plus erlotinib versus erlotinib alone in advanced non-small-cell lung cancer after failure of standard first-line chemotherapy (BeTa): a double-blind, placebo-controlled, phase 3 trial. Lancet (London, England). 377: 1846-54. PMID 21621716 DOI: 10.1016/S0140-6736(11)60545-X |
0.073 |
|
| 2021 |
Brogan J, Bharati A, Moreira D, Rocha A, Bowyer K, Flynn P, Scheirer W. Fast Local Spatial Verification for Feature-Agnostic Large-Scale Image Retrieval. Ieee Transactions On Image Processing : a Publication of the Ieee Signal Processing Society. PMID 34288871 DOI: 10.1109/TIP.2021.3097175 |
0.072 |
|
| 2002 |
Kristinsson G, Flynn P, Rapaport S, Snyder M, Kern JH. PR-segment changes in childhood pericarditis. The Journal of Pediatrics. 140: 378. PMID 11953740 DOI: 10.1067/mpd.2002.121694 |
0.066 |
|
| 2024 |
Flynn P, Suryaprakash S, Grossman D, Panier V, Wu J. The antibody-drug conjugate landscape. Nature Reviews. Drug Discovery. PMID 38627573 DOI: 10.1038/d41573-024-00064-w |
0.064 |
|
| 2006 |
Molina JR, Nikcevich D, Hillman S, Geyer S, Drevyanko T, Jett J, Verdirame J, Tazelaar H, Rowland K, Wos E, Kutteh L, Nair S, Fitch T, Flynn P, Stella P, et al. A Phase II NCCTG study of irinotecan and docetaxel in previously treated patients with non-small cell lung cancer. Cancer Investigation. 24: 382-9. PMID 16777690 DOI: 10.1080/07357900600705318 |
0.055 |
|
| 2014 |
Flynn P, Duncan CG, Palmer RH, Duerr FM. In vitro incidence of fibular penetration with and without the use of a jig during tibial plateau leveling osteotomy. Veterinary Surgery : Vs. 43: 495-9. PMID 24617749 DOI: 10.1111/j.1532-950X.2014.12152.x |
0.053 |
|
| 2019 |
Bretag-Norris R, Gallur L, Flynn P. Heterogeneity in the psychiatric presentation of behavioural variant frontotemporal dementia (bvFTD). Australasian Psychiatry : Bulletin of Royal Australian and New Zealand College of Psychiatrists. 27: 491-495. PMID 31310153 DOI: 10.1177/1039856219860031 |
0.052 |
|
| 2021 |
DuBreuil DM, Chiang BM, Zhu K, Lai X, Flynn P, Sapir Y, Wainger BJ. A high-content platform for physiological profiling and unbiased classification of individual neurons. Cell Reports Methods. 1. PMID 34318289 DOI: 10.1016/j.crmeth.2021.100004 |
0.052 |
|
| 2008 |
Helfman DM, Flynn P, Khan P, Saeed A. Tropomyosin as a regulator of cancer cell transformation. Advances in Experimental Medicine and Biology. 644: 124-31. PMID 19209818 |
0.05 |
|
| 2023 |
Ansari S, Gergely ZR, Flynn P, Li G, Moore JK, Betterton MD. Quantifying yeast microtubules and spindles using the Toolkit for Automated Microtubule Tracking (TAMiT). Biorxiv : the Preprint Server For Biology. PMID 36798368 DOI: 10.1101/2023.02.07.527544 |
0.049 |
|
| 2023 |
Ansari S, Gergely ZR, Flynn P, Li G, Moore JK, Betterton MD. Quantifying Yeast Microtubules and Spindles Using the Toolkit for Automated Microtubule Tracking (TAMiT). Biomolecules. 13. PMID 37371519 DOI: 10.3390/biom13060939 |
0.049 |
|
| 2018 |
Gast CE, Silk AD, Zarour L, Riegler L, Burkhart JG, Gustafson KT, Parappilly MS, Roh-Johnson M, Goodman JR, Olson B, Schmidt M, Swain JR, Davies PS, Shasthri V, Iizuka S, ... Flynn P, et al. Cell fusion potentiates tumor heterogeneity and reveals circulating hybrid cells that correlate with stage and survival. Science Advances. 4: eaat7828. PMID 30214939 DOI: 10.1126/Sciadv.Aat7828 |
0.047 |
|
| 2022 |
Cashin J, Flynn P, Worthington J, Lowe M, Canterbury A, Launhardt K, Crosby I, Sheldon S, Venkateswaran R, Poulton K. An early evaluation of the HISTO SPOT AB ID Class I & II test in cardiothoracic transplant patients. International Journal of Immunogenetics. 49: 317-324. PMID 35989448 DOI: 10.1111/iji.12595 |
0.045 |
|
| 2022 |
Knight K, Flynn PM. Clinical trials involving prisoners: a bioethical perspective. Clinical Investigation. 2: 1147-1149. PMID 36199977 |
0.045 |
|
| 2017 |
Gallur L, Powell A, Flynn P. Recommencing lithium in Older Adults with Bipolar I Disorder. Australasian Psychiatry : Bulletin of Royal Australian and New Zealand College of Psychiatrists. 1039856217738374. PMID 29087206 DOI: 10.1177/1039856217738374 |
0.043 |
|
| 2018 |
Salavitabar A, Flynn P, Holzer RJ. Transcatheter pulmonary valve implantation: valve technology and procedural outcome. Current Opinion in Cardiology. 32: 655-662. PMID 28723838 DOI: 10.1097/HCO.0000000000000444 |
0.038 |
|
| 2023 |
Gerber N, Lutrario C, Rosenthal M, Platt S, Holzer R, Flynn P. Coronary artery dilation in non-hospitalised children with asymptomatic or mild COVID-19. Cardiology in the Young. 1-5. PMID 37905350 DOI: 10.1017/S1047951123003694 |
0.025 |
|
| 2016 |
Flynn P. Why We Celebrate Oncology Nurses. Ons Connect. 31: 51. PMID 27209663 |
0.023 |
|
| 2006 |
Miller D, Flynn PM, Scott IU, Alfonso EC, Flynn HW. In vitro fluoroquinolone resistance in staphylococcal endophthalmitis isolates. Archives of Ophthalmology (Chicago, Ill. : 1960). 124: 479-83. PMID 16606872 DOI: 10.1001/archopht.124.4.479 |
0.022 |
|
| 2011 |
Loehrer PJ, Feng Y, Cardenes H, Wagner L, Brell JM, Cella D, Flynn P, Ramanathan RK, Crane CH, Alberts SR, Benson AB. Gemcitabine alone versus gemcitabine plus radiotherapy in patients with locally advanced pancreatic cancer: An Eastern Cooperative Oncology Group trial Journal of Clinical Oncology. 29: 4105-4112. PMID 21969502 DOI: 10.1200/Jco.2011.34.8904 |
0.022 |
|
| 2017 |
Azad NS, El-Khoueiry A, Yin J, Oberg AL, Flynn P, Adkins D, Sharma A, Weisenberger DJ, Brown T, Medvari P, Jones PA, Easwaran H, Kamel I, Bahary N, Kim G, et al. Combination epigenetic therapy in metastatic colorectal cancer (mCRC) with subcutaneous 5-azacitidine and entinostat; a phase 2 consortium/stand Up 2 cancer study. Oncotarget. PMID 28186961 DOI: 10.18632/Oncotarget.15108 |
0.022 |
|
| 2009 |
Galoian K, Scully S, McNamara G, Flynn P, Galoyan A. Antitumorigenic effect of brain proline rich polypeptide-1 in human chondrosarcoma Neurochemical Research. 34: 2117-2121. PMID 19484491 DOI: 10.1007/s11064-009-0009-6 |
0.017 |
|
| 2022 |
Pines M, Meyer R, Grabowski EF, Flynn P, Kucine N. De novo antiphospholipid antibody syndrome in two infants. Pediatric Blood & Cancer. e30129. PMID 36495261 DOI: 10.1002/pbc.30129 |
0.01 |
|
| 2017 |
Wohl DA, Golin CE, Napravnik S, Knight K, Flynn PM. Reply. Journal of Acquired Immune Deficiency Syndromes (1999). 76: e21-e22. PMID 28796096 DOI: 10.1097/QAI.0000000000001457 |
0.01 |
|
| 2017 |
Wohl DA, Golin CE, Knight K, Flynn PM, Napravnik S. Response Letter. Journal of Acquired Immune Deficiency Syndromes (1999). PMID 28542082 DOI: 10.1097/QAI.0000000000001457 |
0.01 |
|
| 2017 |
Goodsall TM, Flynn P, Attia JR. The scratch test for determining the inferior hepatic margin. The Medical Journal of Australia. 206: 386-387. PMID 28490300 DOI: 10.5694/mja16.01068 |
0.01 |
|
| 2006 |
Ozdek SC, Miller D, Flynn PM, Flynn HW. In vitro antifungal activity of the fourth generation fluoroquinolones against Candida isolates from human ocular infections. Ocular Immunology and Inflammation. 14: 347-51. PMID 17162605 DOI: 10.1080/09273940600976953 |
0.01 |
|
| Hide low-probability matches. |